Growth Metrics

Nexalin Technology (NXL) Operating Expenses (2021 - 2025)

Nexalin Technology has reported Operating Expenses over the past 5 years, most recently at $2.6 million for Q4 2025.

  • Quarterly results put Operating Expenses at $2.6 million for Q4 2025, down 11.43% from a year ago — trailing twelve months through Dec 2025 was $8.6 million (up 9.44% YoY), and the annual figure for FY2025 was $8.6 million, up 9.44%.
  • Operating Expenses for Q4 2025 was $2.6 million at Nexalin Technology, up from $2.4 million in the prior quarter.
  • Over the last five years, Operating Expenses for NXL hit a ceiling of $2.9 million in Q4 2024 and a floor of $602494.0 in Q4 2021.
  • Median Operating Expenses over the past 5 years was $1.5 million (2023), compared with a mean of $1.5 million.
  • Biggest five-year swings in Operating Expenses: tumbled 64.65% in 2022 and later surged 274.02% in 2023.
  • Nexalin Technology's Operating Expenses stood at $602494.0 in 2021, then grew by 24.68% to $751174.0 in 2022, then soared by 118.3% to $1.6 million in 2023, then skyrocketed by 76.55% to $2.9 million in 2024, then decreased by 11.43% to $2.6 million in 2025.
  • The last three reported values for Operating Expenses were $2.6 million (Q4 2025), $2.4 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.